470 related articles for article (PubMed ID: 29964123)
1. Prospective for cytochrome P450 epoxygenase cardiovascular and renal therapeutics.
Imig JD
Pharmacol Ther; 2018 Dec; 192():1-19. PubMed ID: 29964123
[TBL] [Abstract][Full Text] [Related]
2. The roles of CYP450 epoxygenases and metabolites, epoxyeicosatrienoic acids, in cardiovascular and malignant diseases.
Xu X; Zhang XA; Wang DW
Adv Drug Deliv Rev; 2011 Jul; 63(8):597-609. PubMed ID: 21477627
[TBL] [Abstract][Full Text] [Related]
3. Cytochrome P450 epoxygenases, soluble epoxide hydrolase, and the regulation of cardiovascular inflammation.
Deng Y; Theken KN; Lee CR
J Mol Cell Cardiol; 2010 Feb; 48(2):331-41. PubMed ID: 19891972
[TBL] [Abstract][Full Text] [Related]
4. Role of cytochrome P450-epoxygenase and soluble epoxide hydrolase in the regulation of vascular response.
Nayeem MA; Geldenhuys WJ; Hanif A
Adv Pharmacol; 2023; 97():37-131. PubMed ID: 37236764
[TBL] [Abstract][Full Text] [Related]
5. Influence of inflammation on cardiovascular protective effects of cytochrome P450 epoxygenase-derived epoxyeicosatrienoic acids.
Shahabi P; Siest G; Visvikis-siest S
Drug Metab Rev; 2014 Feb; 46(1):33-56. PubMed ID: 24040964
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of cytochrome P450-derived eicosanoids in humans with stable atherosclerotic cardiovascular disease.
Theken KN; Schuck RN; Edin ML; Tran B; Ellis K; Bass A; Lih FB; Tomer KB; Poloyac SM; Wu MC; Hinderliter AL; Zeldin DC; Stouffer GA; Lee CR
Atherosclerosis; 2012 Jun; 222(2):530-6. PubMed ID: 22503544
[TBL] [Abstract][Full Text] [Related]
7. Effects of dronedarone, amiodarone and their active metabolites on sequential metabolism of arachidonic acid to epoxyeicosatrienoic and dihydroxyeicosatrienoic acids.
Karkhanis A; Tram NDT; Chan ECY
Biochem Pharmacol; 2017 Dec; 146():188-198. PubMed ID: 28958841
[TBL] [Abstract][Full Text] [Related]
8. Crosstalk between adenosine receptors and CYP450-derived oxylipins in the modulation of cardiovascular, including coronary reactive hyperemic response.
Nayeem MA; Hanif A; Geldenhuys WJ; Agba S
Pharmacol Ther; 2022 Dec; 240():108213. PubMed ID: 35597366
[TBL] [Abstract][Full Text] [Related]
9. Epoxy Fatty Acids: From Salt Regulation to Kidney and Cardiovascular Therapeutics: 2019 Lewis K. Dahl Memorial Lecture.
Imig JD; Jankiewicz WK; Khan AH
Hypertension; 2020 Jul; 76(1):3-15. PubMed ID: 32475311
[TBL] [Abstract][Full Text] [Related]
10. Genetic variation in the cytochrome P450 epoxygenase pathway and cardiovascular disease risk.
Theken KN; Lee CR
Pharmacogenomics; 2007 Oct; 8(10):1369-83. PubMed ID: 17979511
[TBL] [Abstract][Full Text] [Related]
11. Arachidonic acid metabolism by human cytochrome P450s 2C8, 2C9, 2E1, and 1A2: regioselective oxygenation and evidence for a role for CYP2C enzymes in arachidonic acid epoxygenation in human liver microsomes.
Rifkind AB; Lee C; Chang TK; Waxman DJ
Arch Biochem Biophys; 1995 Jul; 320(2):380-9. PubMed ID: 7625847
[TBL] [Abstract][Full Text] [Related]
12. Role of epoxyeicosatrienoic acids in cardiovascular diseases and cardiotoxicity of drugs.
Zhang Y; Gao L; Yao B; Huang S; Zhang Y; Liu J; Liu Z; Wang X
Life Sci; 2022 Dec; 310():121122. PubMed ID: 36309225
[TBL] [Abstract][Full Text] [Related]
13. Inside epoxyeicosatrienoic acids and cardiovascular disease.
Tacconelli S; Patrignani P
Front Pharmacol; 2014; 5():239. PubMed ID: 25426071
[TBL] [Abstract][Full Text] [Related]
14. Endothelial CYP epoxygenase overexpression and soluble epoxide hydrolase disruption attenuate acute vascular inflammatory responses in mice.
Deng Y; Edin ML; Theken KN; Schuck RN; Flake GP; Kannon MA; DeGraff LM; Lih FB; Foley J; Bradbury JA; Graves JP; Tomer KB; Falck JR; Zeldin DC; Lee CR
FASEB J; 2011 Feb; 25(2):703-13. PubMed ID: 21059750
[TBL] [Abstract][Full Text] [Related]
15. Epoxy Fatty Acids Are Promising Targets for Treatment of Pain, Cardiovascular Disease and Other Indications Characterized by Mitochondrial Dysfunction, Endoplasmic Stress and Inflammation.
McReynolds C; Morisseau C; Wagner K; Hammock B
Adv Exp Med Biol; 2020; 1274():71-99. PubMed ID: 32894508
[TBL] [Abstract][Full Text] [Related]
16. Cytochrome P450-dependent arachidonic acid metabolism in human kidney.
Schwartzman ML; Martasek P; Rios AR; Levere RD; Solangi K; Goodman AI; Abraham NG
Kidney Int; 1990 Jan; 37(1):94-9. PubMed ID: 2105407
[TBL] [Abstract][Full Text] [Related]
17. Epoxy-Oxylipins and Soluble Epoxide Hydrolase Metabolic Pathway as Targets for NSAID-Induced Gastroenteropathy and Inflammation-Associated Carcinogenesis.
Jones RD; Liao J; Tong X; Xu D; Sun L; Li H; Yang GY
Front Pharmacol; 2019; 10():731. PubMed ID: 31293429
[TBL] [Abstract][Full Text] [Related]
18. The cytochrome P450 epoxygenase pathway regulates the hepatic inflammatory response in fatty liver disease.
Schuck RN; Zha W; Edin ML; Gruzdev A; Vendrov KC; Miller TM; Xu Z; Lih FB; DeGraff LM; Tomer KB; Jones HM; Makowski L; Huang L; Poloyac SM; Zeldin DC; Lee CR
PLoS One; 2014; 9(10):e110162. PubMed ID: 25310404
[TBL] [Abstract][Full Text] [Related]
19. Cardiac Disease Alters Myocardial Tissue Levels of Epoxyeicosatrienoic Acids and Key Proteins Involved in Their Biosynthesis and Degradation.
Aliwarga T; Dinh JC; Heyward S; Prasad B; Gharib SA; Lemaitre RN; Sotoodehnia N; Totah RA
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293289
[TBL] [Abstract][Full Text] [Related]
20. Roles of the epoxygenase CYP2J2 in the endothelium.
Askari A; Thomson SJ; Edin ML; Zeldin DC; Bishop-Bailey D
Prostaglandins Other Lipid Mediat; 2013 Dec; 107():56-63. PubMed ID: 23474289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]